Regulation of exogenous bFGF gene mediated by recombinant adeno-associated virus in vitro

Abstract

The regulatory effect of basic fibroblast growth factor (bFGF) mediated by recombinant adeno-associated virus (AAV) in vitro was investigated. Recombinant plasmid pAAV-S3-bFGF, and pSVneo were co-transfected into BHK-21 cells, then the recombinant AAV genome was replicated and packaged with the helper virus HSV1-rc/ΔUL2. The titer of the recombinant rAAV2-tet-off-bFGF was determined by dot-blot assay. MC3T3-E1 cells were infected with rAAV2-tet-off-bFGF. Regulatory effects of Doxycycline (Dox) on bFGF and osteogenic factors were assayed quantitatively by real-time reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. The physical particle titer of rAAV2-tet-off-bFGF successfully constructed was 1.8×10¹² vector genomes/mL, and the virus could infect MC3T3-E1 cells effectively. In MC3T3-E1 cells treated with Dox, the expression levels of exogenous bFGF and osteogenic factors declined to varying degrees. It was concluded that rAAV2-tet-off-bFGF could infect MC3T3 cells efficiently, and this recombinant system could be regulated successfully by Dox in vitro.

Keywords

tetracycline regulatory system / adeno-associated virus / basic fibroblast growth factor / gene regulation

References

[1] DrosseI,VolkmerE,CapannaR,De BiaseP,MutschlerW,SchiekerM.Tissue engineering for bone defect healing: an update on a multi-component approach. Injury, 2008, 39(Suppl 2): S9-20

[2] CohenM M, Jr. The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A, 2006, 140(23): 2646-2706

[3] WuX B,DongX Y,WuZ J,CaoH,NiuD B,QuJ G,WangH,HouY.A novel method for purification of recombinant adeno-associated virus vectors on a large scale. Chin Sci Bull, 2001, 46(6): 485

[4] PonnazhaganS,YoderM C,SrivastavaA.Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.J Virol, 1997, 71(4): 3098-3104

[5] WozneyJ M,RosenV,CelesteA J,MitsockL M,WhittersM J,KrizR W,HewickR M, WangE A.Novel regulators of bone formation: molecular clones and activities. Science, 1988, 242(4885): 1528-1534

[6] FranceschiR T.Biological approaches to bone regeneration by gene therapy. J Dent Res, 2005, 84(12): 1093-1103

[7] GossenM,BujardH.Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA, 1992, 89(12):5547-5551

[8] FreundliebS,Schirra-MullerC,BujardH. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med, 1999, 1(1): 4-12

[9] SongK,RaoN J,ChenM L,CaoY G.Construction of adeno-associated virus system for human bone morphogenetic protein 7 gene. J Huazhong Univ Sci Technolog Med Sci, 2008, 28(1): 17-21

[10] ConwayJ E,RhysC M,ZolotukhinI,ZolotukhinS,MuzyczkaN,HaywardG S,ByrneB J. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther, 1999, 6(6):986-993

[11] KnopD R,HarrellH.Bioreactor production of recombinant herpes simplex virus vectors. Biotechnol Prog, 2007, 23(3): 715-721

[12] YangM,MaQ J,DangG T,MaK T,ChenP,ZhouC Y.Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells. Acta Pharmacol Sin, 2005, 26(8):963-968

[13] HauswirthW W,LewinA S,ZolotukhinS,MuzyczkaN.Production and purification of recombinant adeno-associated virus. Methods Enzymol, 2000, 316: 743-761

[14] HanG C,LiY,WangJ N,WangR X,ChenG J,SongL,Xu,R N,YuM,WuX B,QianJ H, ShenB F.Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD (500-585). J Immunol, 2005, 174(8): 4516-4524

[15] YanH,GuoY H,ZhangP,ZuL Y,DongX Y,ChenL,TianJ W,FanX L,WangN P,WuX B,GaoW.Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. Biochem Biophys Res Commun, 2005, 336(1): 287-298

[16] OrnitzD M,ItohN.Fibroblast growth factors. Genome Biol, 2001,2(3): REVIEWS3005

[17] NaganawaT,XiaoL P,CoffinJ D,DoetschmanT,SabbietiM G,AgasD,HurleyM M. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem, 2008, 103(6): 1975-1988

[18] AgataH,AsahinaI,YamazakiY,UchidaM,ShinoharaY,HondaM J,KagamiH,UedaM. Effective bone engineering with periosteum-derived cells. J Dent Res, 2007, 86(1): 79-83

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg